Taiwan Sci-Tech Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Taiwan Sci-Tech Weekly.

Press releases published on April 22, 2026

Apr. 22, 2026

Cloudbreak Pharma Announces Presentation on its Multi-Kinase Inhibition (MKI) Platform and Ongoing Clinical Programs at Eyecelerator @ ARVO 2026

Indeterminate GlobeNewswire

Apr. 22, 2026

Humacyte Appoints Jim Mercadante as Chief Commercial Officer

Indeterminate GlobeNewswire

Apr. 22, 2026

Corbus Pharmaceuticals Announces Abstracts Accepted for Presentation at ASCO 2026 Featuring Updated Clinical Data for CRB-701

Indeterminate GlobeNewswire

Apr. 22, 2026

Paratus Appoints Alicia Secor as President and Chief Executive Officer; Expands Leadership Team to Support Next Phase of Growth

Indeterminate GlobeNewswire

Apr. 22, 2026

Neurona Presents Updated Data from Ongoing Clinical Trials of Rezanecel (NRTX-1001) Regenerative Cell Therapy in Mesial Temporal Lobe Epilepsy at 2026 American Academy of Neurology (AAN) Annual Meeting 

Indeterminate GlobeNewswire

Apr. 22, 2026

Arcutis’ ZORYVE® (roflumilast) Cream Receives Strong Recommendation in American Academy of Dermatology First-Ever Pediatric Atopic Dermatitis Guidelines

Indeterminate GlobeNewswire

Apr. 22, 2026

Axe Compute Secures $260 million, Three-Year Enterprise Contract for 2,304-GPU NVIDIA B300 Deployment

Indeterminate GlobeNewswire

Apr. 22, 2026

Tempest Announces Key Manufacturing Milestone for TPST-2003 Dual-Targeting CD19/BCMA CAR-T

Indeterminate GlobeNewswire

Apr. 22, 2026

Immutep Announces Abstract Accepted for Presentation at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting

Indeterminate GlobeNewswire

Apr. 22, 2026

The Invoicing “Time Tax”: Why 5 Hours of Manual Work is Now the Leading Predictor of Small Business Cash-Flow Risk

Indeterminate GlobeNewswire

Apr. 22, 2026

Glyco Harmony Drops Examined - 2026 Consumer-Focused Report on Ingredients, Claims & Label Insights

Indeterminate GlobeNewswire

Apr. 22, 2026

BullFrog AI Regains Compliance with Nasdaq Shareholders’ Equity Requirement

Indeterminate GlobeNewswire

Apr. 22, 2026

Repligen to Report First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Apr. 22, 2026

CervoMed Announces New Data at the 2026 AAN Annual Meeting that Demonstrated Neflamapimod Increased Basal Forebrain Volume and Functional Connectivity in Dementia with Lewy Bodies

Indeterminate GlobeNewswire

Apr. 22, 2026

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2026 Annual Meeting

Indeterminate GlobeNewswire

Apr. 22, 2026

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Apr. 22, 2026

Viomi Technology Co., Ltd Filed 2025 Annual Report on Form 20-F

Indeterminate GlobeNewswire

Apr. 22, 2026

Alterity Therapeutics Presents New Analysis of ATH434 Phase 2 Trial Data in Late Breaking Science Session of the American Academy of Neurology

Indeterminate GlobeNewswire

Apr. 22, 2026

Coave Therapeutics to present two posters at ARVO 2026, on first-in-class ligand-conjugated suprachoroidal vector and lead gene therapy program

Indeterminate GlobeNewswire

Apr. 22, 2026

Geron Plans to Announce First Quarter 2026 Financial Results on May 6, 2026

Indeterminate GlobeNewswire